Abiopharma

Castle Biosciences - Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2

OKYO Pharma to Ring the Opening Bell at Nasdaq

Josh Swihart, ECC CEO, Joins Cypherpunk as Strategic Advisor

Altimmune Announces that Pemvidutide Achieved Key Measures of Success at 48 Weeks in IMPACT Phase 2b MASH Trial

Grifols Communication - Grifols receives US FDA approval for new fibrinogen concentrate, FESILTYTM

Ensign Group - The Ensign Group, Inc. Increases Quarterly Dividend to $0.0650 Per Share

The Ensign Group, Inc. Increases Quarterly Dividend to $0.0650 Per Share